PL408194A1 - Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation - Google Patents

Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation

Info

Publication number
PL408194A1
PL408194A1 PL408194A PL40819414A PL408194A1 PL 408194 A1 PL408194 A1 PL 408194A1 PL 408194 A PL408194 A PL 408194A PL 40819414 A PL40819414 A PL 40819414A PL 408194 A1 PL408194 A1 PL 408194A1
Authority
PL
Poland
Prior art keywords
radiation
products
intended
aging
increased resistance
Prior art date
Application number
PL408194A
Other languages
Polish (pl)
Other versions
PL225134B1 (en
Inventor
Anna Marzec
Marian Zaborski
Zygmunt Boruszczak
Anna Laskowska
Original Assignee
Politechnika Łódzka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Łódzka filed Critical Politechnika Łódzka
Priority to PL408194A priority Critical patent/PL225134B1/en
Publication of PL408194A1 publication Critical patent/PL408194A1/en
Publication of PL225134B1 publication Critical patent/PL225134B1/en

Links

Landscapes

  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Przedmiotem rozwiązania jest kompozycja elastomerowa zawierająca cykliczny kopolimer etylenowo - norbornenowy oraz substancję przeciwstarzeniową. Jako substancję przeciwstarzeniową zawiera pochodną antrachinonu powstałą w wyniku podstawienia antrachinonu w pozycjach 1; 1,4; 1,5; 1,8; 1, 4, 5, 8 podstawnikami elektronodonorowymi. Wprowadzenie do cyklicznego kopolimeru etylenowo - norbornenowego takich pochodnych antrachinonu powoduje wyraźne podwyższenie jego odporności na starzenie klimatyczne i promieniowanie UV.The subject of the solution is an elastomer composition containing a cyclic ethylene-norbornene copolymer and an anti-aging substance. As an anti-aging substance it contains an anthraquinone derivative resulting from substitution of anthraquinone in positions 1; 1.4; 1.5; 1.8; 1, 4, 5, 8 electron-donating substituents. The introduction of such anthraquinone derivatives into the cyclic ethylene-norbornene copolymer causes a significant increase in its resistance to climatic aging and UV radiation.

PL408194A 2014-05-12 2014-05-12 Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation PL225134B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL408194A PL225134B1 (en) 2014-05-12 2014-05-12 Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL408194A PL225134B1 (en) 2014-05-12 2014-05-12 Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation

Publications (2)

Publication Number Publication Date
PL408194A1 true PL408194A1 (en) 2015-11-23
PL225134B1 PL225134B1 (en) 2017-02-28

Family

ID=54543790

Family Applications (1)

Application Number Title Priority Date Filing Date
PL408194A PL225134B1 (en) 2014-05-12 2014-05-12 Elastomeric composition, intended for the products with increased resistance to climatic aging and UV radiation

Country Status (1)

Country Link
PL (1) PL225134B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL234582B1 (en) * 2017-06-28 2020-03-31 Politechnika Lodzka Elastomeric composition, intended for the products with increased resistance to weather and climatic ageing

Also Published As

Publication number Publication date
PL225134B1 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
CL2017002445A1 (en) Variants of pertuzumab and its evaluation.
BR112015019432A2 (en) TUBULISIN COMPOUNDS, PRODUCTION METHODS AND USE
CL2016002772A1 (en) Fast-acting insulin compositions
EP3253727A4 (en) Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
UA116467C2 (en) P2x7 modulators
BR112016023851A2 (en) ? two-part coating composition and method for coating a surface?
TW201612178A (en) Organic semiconductor composition comprising a liquid medium
MX373176B (en) NITROXYL DONORS WITH IMPROVED THERAPEUTIC INDEX.
BR112016019510A2 (en) sterilization and filtration of peptide compositions
MX394313B (en) AQUEOUS COATING COMPOSITION AND PROCESS THEREOF.
MX378201B (en) MARKING COMPOSITION.
UY35997A (en) ISOQUINOLEINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
MX2017003365A (en) High wet fast disperse dyes and mixtures thereof.
DOP2017000058A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMINUM INHIBITORS
MX2017007577A (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof.
EP3720597C0 (en) MACROMOLECULAR COMPOSITIONS CONTAINING INDENDER DERIVATIVES
IL259891A (en) Organic solvent-free compositions containing conjugates of protein and polymer, and their uses
BR112016006963A2 (en) pharmaceutical composition
BR112014014572A2 (en) bioactive composition
HRP20181112T1 (en) SUBSTITUTED DERIVATIVES OF AZASPIRO (4,5) DEKAN
MX2015008586A (en) Liquid stevia compositions.
BR112017011186A2 (en) prepeg vinyl ester powder
HRP20180940T1 (en) DERIVATIVES OF THE SUBSTITUTED AZASPIRO (4,5) DEKAN
NI201500172A (en) PHARMACEUTICAL COMPOSITIONS